Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.435
-0.115 (-7.42%)
Mar 31, 2025, 1:41 PM EDT - Market open
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $311.77 million as of March 31, 2025. Its market cap has decreased by -62.03% in one year.
Market Cap
311.77M
Enterprise Value
112.23M
1-Year Change
-62.03%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $311.77M, a decrease of -89.18%. That is a compound annual growth rate of -29.10%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.46B |
| UnitedHealth Group | 477.03B |
| Johnson & Johnson | 399.09B |
| AbbVie | 365.90B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 228.63B |
| Merck & Co. | 224.72B |